Palvella Therapeutics (NasdaqCM:PVLA) Update / briefing Transcript
2026-02-24 14:02
Palvella Therapeutics (NasdaqCM:PVLA) Update / briefing February 24, 2026 08:00 AM ET Company ParticipantsAnnabel Samimy - Managing DirectorBohan Wei - VP of Corporate Development and New Product PlanningCatherine Novack - Director of Healthcare Equity ResearchGraig Suvannavejh - Managing DirectorJeff Martini - Chief Scientific OfficerJosh Schimmer - Managing DirectorMichael Kelly - Pediatric Hematologist-OncologistWes Kaupinen - Founder and CEOConference Call ParticipantsAlbert Lowe - Senior Equity Researc ...